2 news items
Windtree Therapeutics Regains Compliance With Nasdaq
WINT
7 May 24
innovative therapies for critical conditions and diseases, today announced it has received a Bid Price Compliance Letter from The Nasdaq Stock Market LLC
Windtree Acquires Early-Stage, Novel Oncology Platform and Completes $1.5 Million Convertible Note Bridge Financing
WINT
8 Apr 24
acquisition and the bridge financing represents a potentially transformative next step for Windtree. Adding an innovative protein kinase inhibitor
- Prev
- 1
- Next